Plastic selection is one of the most influential decisions in medical and biotech manufacturing. The chosen material affects not only product performance but also manufacturability, regulatory compliance, and long-term reliability. In regulated industries, material decisions must balance technical requirements with process control and documentation.
Medical and biotech products are exposed to demanding conditions. They may come into contact with biological samples, chemicals, or reagents, and often must withstand sterilization processes such as gamma irradiation, ethylene oxide, or autoclaving. The selected plastic must maintain its mechanical and chemical properties under these conditions without degrading or leaching substances that could compromise results or safety.
Polypropylene remains one of the most widely used materials in medical and life science manufacturing. Its chemical resistance, flexibility, and cost-effectiveness make it suitable for consumables such as tubes, containers, and housings. Polycarbonate is favored when higher strength or transparency is required, while cyclic olefin copolymers are increasingly used in diagnostic applications due to their optical clarity and low extractables.
Beyond performance, processing behavior plays a critical role in material selection. Some plastics mold more consistently than others, offering wider processing windows and reduced variability. In regulated manufacturing, predictable processing simplifies validation and reduces scrap rates. Materials with narrow processing tolerances may require tighter controls and higher production costs.
Regulatory considerations further influence plastic selection. Medical-grade materials must be traceable and supported by documentation from reputable suppliers. Manufacturers must maintain records of material specifications, lot numbers, and certifications. Using well-characterized materials simplifies audits and regulatory submissions while reducing compliance risk.
Long-term stability is another important factor. Medical and biotech products may be stored for extended periods before use. Plastics must maintain dimensional stability, mechanical integrity, and chemical compatibility throughout their shelf life. Stability testing helps confirm that materials perform as intended over time.
Sustainability is also becoming part of the conversation. While performance and compliance remain top priorities, manufacturers are exploring ways to optimize material usage and reduce waste. Efficient molding processes and thoughtful material selection can improve sustainability without compromising quality.
Selecting the right plastic requires a holistic approach. Performance, processing, compliance, and long-term reliability must all be considered together. By working with experienced manufacturing partners, medical and biotech companies can make informed material choices that support product success and regulatory confidence.
